Cargando…
P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431471/ http://dx.doi.org/10.1097/01.HS9.0000971024.48080.f5 |
_version_ | 1785091210699866112 |
---|---|
author | Gerds, Aaron T. Grunwald, Michael Oh, Stephen Braunstein, Evan Xue, Zhenyi Bhatt, Valkal Yu, Jingbo Mesa, Ruben |
author_facet | Gerds, Aaron T. Grunwald, Michael Oh, Stephen Braunstein, Evan Xue, Zhenyi Bhatt, Valkal Yu, Jingbo Mesa, Ruben |
author_sort | Gerds, Aaron T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104314712023-08-17 P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL Gerds, Aaron T. Grunwald, Michael Oh, Stephen Braunstein, Evan Xue, Zhenyi Bhatt, Valkal Yu, Jingbo Mesa, Ruben Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431471/ http://dx.doi.org/10.1097/01.HS9.0000971024.48080.f5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Gerds, Aaron T. Grunwald, Michael Oh, Stephen Braunstein, Evan Xue, Zhenyi Bhatt, Valkal Yu, Jingbo Mesa, Ruben P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL |
title | P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL |
title_full | P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL |
title_fullStr | P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL |
title_full_unstemmed | P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL |
title_short | P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL |
title_sort | p1032: characteristics and clinical outcomes in patients (pts) with polycythemia vera (pv) receiving ruxolitinib (rux) after hydroxyurea (hu): a longitudinal analysis from reveal |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431471/ http://dx.doi.org/10.1097/01.HS9.0000971024.48080.f5 |
work_keys_str_mv | AT gerdsaaront p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT grunwaldmichael p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT ohstephen p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT braunsteinevan p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT xuezhenyi p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT bhattvalkal p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT yujingbo p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal AT mesaruben p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal |